An observational study in Crohn's Disease, Ulcerative Colitis and Inflammatory Bowel Diseases, sponsored by Dartmouth-Hitchcock Medical Center. Enrolling by invitation at 29 sites in United States. Open to participants aged 18 Years to 99 Years. Per ClinicalTrials.gov, last updated 2025-08-21.
Sponsored by Dartmouth-Hitchcock Medical Center · Observational
Innovative programs exist that suggest that care for people with chronic conditions is optimized when patients and providers have the information they need at the point of care and over time, to engage in shared planning and execution of treatment goals and care plans. This project aims to build an Inflammatory Bowel Disease Learning Health System, a shared information environment, that highlights collaboration among patients, clinicians and care team members, and researchers; for effective use of data for guiding care, value, improvement, and research.
To demonstrate the impact of an Adult Inflammatory Bowel Disease (IBD) Learning Health System approach the study collaborators will design, build, implement, and evaluate in up to 90 IBD care sites the the following four key components of the IBD Learning Health System: 1) a Health Information Technology (HIT) environment that can "feed-forward" Patient Reported Outcomes (PROs) and clinical data to be used at the point of care and integrated into a registry (IBD Plexus); 2) decision-support dashboards for use by patients and clinicians in real time to coproduce care; 3) meaningful reports for patients and clinicians; and 4) multi-stakeholder collaborative networks for improvement and research.
Prior work from Sweden and the US show that successful uptake of the model can offer important benefits. Patients will be able to use web-based tools to monitor their health and manage their care, securely share data with clinicians in a timely manner, visualize outcomes that matter to them, and compare their results to other people. Clinicians will have new information that can improve their ability to track patient outcomes and costs over time; use PRO data to support pre-visit planning, shared decision-making at the point of care, and post-visit monitoring; and receive comparative performance reports to support quality improvement, public reporting, and professional development. Researchers will benefit by having PROs and cost data added to data registries to support clinical, translational, and comparative effectiveness research.
1,880 studies on the registry are indexed under Crohn Disease; 462 are open to participants now.
This study's planned enrollment of 10,000 is above the median of 162 across 608 observational studies indexed under Crohn Disease.
Browse Crohn Disease studies →Dartmouth-Hitchcock Medical Center is the lead sponsor of 472 studies on the registry; 68 are open to participants now.
Of its 30 completed or terminated interventional studies of FDA-regulated products, 20 (67%) have results posted.
Counted across the registry records on this site, refreshed daily.
In order to participate in IBD Qorus, individuals must meet the following criteria:
Exclusion Criteria:
This is a registry study, the same information is collected from all participants.
Number of patients enrolled
count of number of patients consented
Time frame: annually, up to 5 years
Proportion of patients in remission
assessed using a validated disease activity scale
Time frame: annually, up to 5 years
Proportion of patients on steroids
assessed by patient report
Time frame: annually, up to 5 years
Proportion of patients admitted into the Emergency Room
assessed by patient report
Time frame: annually, up to 5 years
Proportion of patients hospitalized
assessed by patient report
Time frame: annually, up to 5 years
Proportion of patients with anemia
assessed by patient report and labs
Time frame: annually, up to 5 years
Proportion of patients with malnutrition
assessed by patient report and labs
Time frame: annually, up to 5 years
Plan to share: Undecided
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Dartmouth-Hitchcock Medical Center